- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Samrat Pharmachem Ltd (SAMR)
Samrat Pharmachem Ltd stock price live, this page displays BO SAMR stock exchange data. View the SAMR premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Samrat Pharmachem Ltd real time stock price chart below.
What Is the Samrat Pharmachem Ltd Stock Price Today?
The Samrat Pharmachem Ltd stock price today is 349.95.
What Is the Stock Symbol for Samrat Pharmachem Ltd?
The stock symbol for Samrat Pharmachem Ltd is ""SAMR.""
What Stock Exchange Does Samrat Pharmachem Ltd Trade On?
Samrat Pharmachem Ltd is listed and trades on the BSE stock exchange.
Is Samrat Pharmachem Ltd a Good Stock to Buy?
Determining whether Samrat Pharmachem Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SAMR quote. (ISIN: INE103E01016)
What Is the Samrat Pharmachem Ltd Stock Price Today?
The Samrat Pharmachem Ltd stock price today is 349.95.
What Is the Stock Symbol for Samrat Pharmachem Ltd?
The stock symbol for Samrat Pharmachem Ltd is ""SAMR.""
What Stock Exchange Does Samrat Pharmachem Ltd Trade On?
Samrat Pharmachem Ltd is listed and trades on the BSE stock exchange.
Is Samrat Pharmachem Ltd a Good Stock to Buy?
Determining whether Samrat Pharmachem Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SAMR quote. (ISIN: INE103E01016)
BSE
Currency in INR
349.95
+3.10(+0.89%)
Delayed Data·
Fair Value
An estimate of a Samrat Pharmachem's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
345.00
354.90
52 wk Range
302.05
646.00
SAMR Scorecard
Full Analysis
Suffers from weak gross profit margins
SAMR is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Samrat Pharmachem's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
345.00354.90
52 wk Range
302.05646.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.29%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.29%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
SAMR Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Samrat Pharmachem's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock price often moves in the opposite direction of the market
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell
Samrat Pharmachem Ltd Company Profile
Samrat Pharmachem Limited engages in the manufacture and sale of pharmaceutical chemicals in India. It offers 3-5-di iodosalicylic acid, ammonium iodide, cadmium iodide, calcium iodate, clioquinol, copper iodide, ethyl iodide, ethylenediamine dihydroiodide, hydroiodic acid, iodic acid, iodine, iodine monochloride, iodoquinol, lithium iodide, methyl iodide, n-iodo succinimide, periodic acid, potassium iodate, potassium iodide, potassium metaper iodate, povidone iodine, selenium dioxide, sodium iodate, sodium iodide, sodium metaper iodate, sodium selenite, and tri methyl sulphoxonium iodide. The company serves agrochemical, animal feed, chemical, cosmetics, food, LCD screen, contrast media, pharmaceutical, screen printing, nylon textile, and tire cord manufacturing industries. It also exports its products to the United States, Europe, Africa, Asia, the Middle East, and internationally. Samrat Pharmachem Limited was incorporated in 1992 and is based in Mumbai, India.
Compare SAMR to Peers and Sector
Metrics to compare | SAMR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSAMRPeersSector | |
|---|---|---|---|---|
P/E Ratio | 15.1x | 34.5x | 2.5x | |
PEG Ratio | 0.07 | 0.41 | 0.00 | |
Price/Book | 1.5x | 2.6x | 1.6x | |
Price / LTM Sales | 0.4x | 1.3x | 1.3x | |
Upside (Analyst Target) | - | −3.3% | 19.4% | |
Fair Value Upside | Unlock | −6.8% | 2.2% | Unlock |
Earnings
Latest Release
May 30, 2025
EPS / Forecast
-1.29 / --
Revenue / Forecast
710.96M / --
People Also Watch
FAQ
What Stock Exchange Does Samrat Pharmachem Trade On?
Samrat Pharmachem is listed and trades on the Bombay Stock Exchange stock exchange.
What Is the Stock Symbol for Samrat Pharmachem?
The stock symbol for Samrat Pharmachem is "SAMR."
What Is the Samrat Pharmachem Market Cap?
As of today, Samrat Pharmachem market cap is 1.08B.
What Is Samrat Pharmachem's Earnings Per Share (TTM)?
The Samrat Pharmachem EPS (TTM) is 23.02.
From a Technical Analysis Perspective, Is SAMR a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Samrat Pharmachem Stock Split?
Samrat Pharmachem has split 0 times.
How Many Employees Does Samrat Pharmachem Have?
Samrat Pharmachem has 32 employees.
What is the current trading status of Samrat Pharmachem (SAMR)?
As of 30 Jul 2025, Samrat Pharmachem (SAMR) is trading at a price of 349.95, with a previous close of 346.85. The stock has fluctuated within a day range of 345.00 to 354.90, while its 52-week range spans from 302.05 to 646.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.